Innate Lymphoid Cell Aging
Innate Lymphoid Cell Aging
批准号:
10207444
负责人:
Qi yang
金额:
$10.83万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-30 至 2021-10-22
关键词:
Adoptive TransferAgeAgingAntibody ResponseCell AgingCell CountCellsCommunicable DiseasesDataDevelopmentDiseaseDoseElderlyGoalsHost DefenseHumanHypersensitivityImmuneImmune systemImpairmentIn VitroIndividualInfectionInfluenzaInfluenza A virusKnockout MiceLongevityLungLymphocyteLymphoid CellMaintenanceMolecularMonitorMusPredispositionPublic HealthReporterResistanceResistance to infectionRoleSignal TransductionTCF Transcription FactorTestingTissuesVirus DiseasesWorkagedbasecombatconditional knockoutefficacy testingexperimental studygranulocytehealingimmunoregulationimmunosenescenceimprovedin vivoinfluenza infectioninsightmouse modelnovelprogenitorresponseself-renewalstem cellstissue regenerationtranscription factortranscriptome sequencing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Innate lymphoid cells (ILC) are recently discovered tissue-resident self-renewing immune cells with
critical roles in barrier defense, tissue regeneration and immune regulation. Our preliminary data indicate that
ILC gradually diminish in number with age. The goal of this project is to understand the cellular and molecular
mechanisms that result in loss of ILC with age, and to examine whether diminished ILC numbers contribute to
increased susceptibility to infections and diseases in the aged. This project focuses on group-2 innate
lymphoid cells (ILC2), the predominant ILC subset in the lung. We hypothesize that decreased TCF-1
expression impairs ILC2 self-renewal and results in diminished numbers of ILC2 with age, and that diminished
ILC2 responses contribute to increased susceptibility to influenza infection in the aged. We will use novel TCF-
1YFP and TCF-1 conditional knockout mice to explore the cellular and molecular mechanisms that control the
longevity and self-renewal of lung-resident ILC2. We will determine whether dysregulation of such mechanisms
results in loss of ILC2 with age. We will further use adoptive transfer approaches to examine whether and how
diminished ILC2 responses contribute to increased susceptibility to influenza in aged mice. Finally, we will
develop strategies to restore ILC2 numbers in the aged, and will test the efficacy of these strategies to
enhance resistance to influenza in old mice. We anticipate that this work will provide significant insights into
lymphocyte aging, and will inform strategies to improve immune defense in the elderly.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The development and function of aging-associate innate lymphoid cells in the choroid plexus
-
批准号:10659515
-
项目类别:
-
资助金额:$186.13万
-
财政年份:2023
-
负责人:Qi yang
-
依托单位:
Function and regulation of mucosal associated invariant T cells in the lung
-
批准号:10291011
-
项目类别:
-
资助金额:$5.82万
-
财政年份:2021
-
负责人:Qi yang
-
依托单位:
Innate Lymphoid Cell Aging
-
批准号:10531485
-
项目类别:
-
资助金额:$22.38万
-
财政年份:2021
-
负责人:Qi yang
-
依托单位:
Function and regulation of mucosal associated invariant T cells in the lung
-
批准号:10646480
-
项目类别:
-
资助金额:$55.66万
-
财政年份:2021
-
负责人:Qi yang
-
依托单位:
Function and regulation of mucosal associated invariant T cells in the lung
-
批准号:10434942
-
项目类别:
-
资助金额:$55.66万
-
财政年份:2021
-
负责人:Qi yang
-
依托单位:
Function and regulation of mucosal associated invariant T cells in the lung
-
批准号:10531769
-
项目类别:
-
资助金额:$51.97万
-
财政年份:2021
-
负责人:Qi yang
-
依托单位:
Development and function of inflammatory innate lymphoid cells
-
批准号:9918449
-
项目类别:
-
资助金额:$40.41万
-
财政年份:2018
-
负责人:Qi yang
-
依托单位:
Development and function of inflammatory innate lymphoid cells
-
批准号:10533596
-
项目类别:
-
资助金额:$23.63万
-
财政年份:2018
-
负责人:Qi yang
-
依托单位:
Early Innate Lymphoid Cell Development
-
批准号:9302283
-
项目类别:
-
资助金额:$10.71万
-
财政年份:2016
-
负责人:Qi yang
-
依托单位:
Early Innate Lymphoid Cell Development
-
批准号:9034021
-
项目类别:
-
资助金额:$16.2万
-
财政年份:2016
-
负责人:Qi yang
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: